PharmacyCodes



Bromocriptina [Inn-Spanish] en es it fr

Bromocriptina [Inn-Spanish] Brand names, Bromocriptina [Inn-Spanish] Analogs

Bromocriptina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Bromocriptina [Inn-Spanish] Chemical_Formula

C32H40BrN5O5

Bromocriptina [Inn-Spanish] RX_link

http://www.rxlist.com/cgi/generic3/bromocriptine.htm

Bromocriptina [Inn-Spanish] fda sheet

Bromocriptina [Inn-Spanish] msds (material safety sheet)

Bromocriptina [Inn-Spanish] Synthesis Reference

No information avaliable

Bromocriptina [Inn-Spanish] Molecular Weight

654.595 g/mol

Bromocriptina [Inn-Spanish] Melting Point

No information avaliable

Bromocriptina [Inn-Spanish] H2O Solubility

No information avaliable

Bromocriptina [Inn-Spanish] State

Solid

Bromocriptina [Inn-Spanish] LogP

No information avaliable

Bromocriptina [Inn-Spanish] Dosage Forms

Capsule

Bromocriptina [Inn-Spanish] Indication

For treatment of idiopathic or postencephalitic Parkinson's disease, dysfunctions associated with hyperprolactinemia and in the treatment of acromegaly.

Bromocriptina [Inn-Spanish] Pharmacology

Bromocriptine is an ergoline derivitave dopamine agonist that is used in the treatment of amenorrhea, female infertility, abnormal discharge of breast milk, hypogonadism, Parkinson's disease, and acromegaly. Bromocriptine produces its therapeutic effect in the treatment of Parkinson's disease, a clinical condition characterized by a progressive deficiency in dopamine synthesis in the substantia nigra, by directly stimulating the dopamine receptors in the corpus striatum.

Bromocriptina [Inn-Spanish] Absorption

No information avaliable

Bromocriptina [Inn-Spanish] side effects and Toxicity

No information avaliable

Bromocriptina [Inn-Spanish] Patient Information

Bromocriptina [Inn-Spanish] Organisms Affected

Humans and other mammals